Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Villard

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Swiss Medical Weekly|April 25, 2006
Immunity after organ transplantationJean Villard
Journal of Innate Immunity|March 18, 2011
The role of natural killer cells in human solid organ and tissue transplantationJean Villard
Swiss Medical Weekly|December 14, 2004
Transcription regulation and human diseasesJean Villard
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|May 15, 2004
Cellular and gene therapy for major histocompatibility complex class II deficiencyFranck Matheux, Jean Villard
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2013
Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cellsCasimir de Rham, Jean Villard
Journal of Immunology Research|August 16, 2014
Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapyCasimir de Rham, Jean Villard
Seminars in Immunopathology|April 5, 2011
How to cross immunogenetic hurdles to human embryonic stem cell transplantationCasimir de Rham, Jean Villard
Immunogenetics|June 29, 2004
A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid originJean-Marie Tiercy, Jean Villard
Clinical Transplantation|February 9, 2022
Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatmentsMassimiliano Bertacchi, Paloma Parvex, Jean Villard
Revue Medicale Suisse|May 16, 2009
[Can we do without intravenous polyclonal immunoglobines (IVIg)?]Fabienne Gary-Crosier, Urs Nydegger, Jean Villard
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Swiss Medical Weekly|April 25, 2006
Immunity after organ transplantationJean Villard
Journal of Innate Immunity|March 18, 2011
The role of natural killer cells in human solid organ and tissue transplantationJean Villard
Swiss Medical Weekly|December 14, 2004
Transcription regulation and human diseasesJean Villard
News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society|May 15, 2004
Cellular and gene therapy for major histocompatibility complex class II deficiencyFranck Matheux, Jean Villard
Methods in Molecular Biology (Clifton, N.J.)|June 13, 2013
Interaction of ES cell derived neural progenitor cells with natural killer cells and cytotoxic T cellsCasimir de Rham, Jean Villard
Journal of Immunology Research|August 16, 2014
Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapyCasimir de Rham, Jean Villard
Seminars in Immunopathology|April 5, 2011
How to cross immunogenetic hurdles to human embryonic stem cell transplantationCasimir de Rham, Jean Villard
Immunogenetics|June 29, 2004
A new DR7-DQ8 haplotype resulting from a recombination between the DQA1 and DQB1 loci in a leukemic patient of Caucasoid originJean-Marie Tiercy, Jean Villard
Clinical Transplantation|February 9, 2022
Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatmentsMassimiliano Bertacchi, Paloma Parvex, Jean Villard
Revue Medicale Suisse|May 16, 2009
[Can we do without intravenous polyclonal immunoglobines (IVIg)?]Fabienne Gary-Crosier, Urs Nydegger, Jean Villard
Pageof 11